West Health



Big, Small Plans Split On Medicare Drug Price Negotiation

Insurers benefit from the high prices in the current system because their profits are percentage-based, so as costs go up, so do their profits, according to Sean Dickson, West Health director of Health Policy.

The Crushing Impact of High Healthcare Costs on Seniors

West Health’s Shelley Lyford, president and chief executive officer, and Dr. Zia Agha, chief medical officer and executive vice president, join the Gallup Podcast to discuss the master plan and how West Health’s approach can address different needs and sectors that touch a senior citizen’s life.

Domestic Reference Pricing Would’ve Cut Launch Prices 18%-30%

Medicare would have saved 18% to 30% on newly launched drugs from 2015 to 2019 if it had used domestic reference pricing to control prices, and domestic reference prices for most drugs were even above the prices suggested by the Institute for Clinical and Economic Review, according to a report by West Health Policy Center, the University of Pittsburgh and the University of California, San Diego.

18 Million Americans Can’t Pay for Needed Meds

By Steven Reinberg September 22, 2021 As many as 18 million Americans can’t afford their prescribed medications, a new nationwide poll finds. That’s 7% of the adult population in the United States. But when it comes to households making less than $24,000 per year, the percentage jumps to 19%, the West Health/Gallup poll revealed. Here… Read more »